Advertisement
Screener

GREENWICH LIFESCIENCES, INC. (GLSI) Deferred Tax Assets, Operating Loss Carryforwards

2.4 / 5 stars · 16/33 Roast Me

GREENWICH LIFESCIENCES, INC. Deferred Tax Assets, Operating Loss Carryforwards

GREENWICH LIFESCIENCES, INC. (GLSI) had Deferred Tax Assets, Operating Loss Carryforwards of $9.28 million as of 2025-12-31, per its 10-K filed 2026-06-01.

Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance

us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-06-01

  • 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $9.28M.
  • 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $6.64M; Deferred Tax Assets, Operating Loss Carryforwards as first filed $6.30M.
  • 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $4.51M.
  • 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $3.14M.
Period endDeferred Tax Assets, Operating Loss CarryforwardsDeferred Tax Assets, Operating Loss Carryforwards as first filed
2025-12-31$9.28M
10-K · filed 2026-06-01
2024-12-31$6.64M
10-K · filed 2026-06-01
$6.30M
10-K · filed 2025-04-15
2023-12-31$4.51M
10-K · filed 2025-04-15
2022-12-31$3.14M
10-K · filed 2024-04-15
2021-12-31$1.86M
10-K · filed 2023-03-31
2020-12-31$1.04M
10-K · filed 2022-03-21
2019-12-31$790.33K
10-K · filed 2021-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
Mereo BioPharma Group plc (MREO)$0.269B-9.41
Akebia Therapeutics, Inc. (AKBA)United States$0.255B-10.35
Sagimet Biosciences Inc. (SGMT)United States$0.279B
Upstream Bio, Inc. (UPB)United States$0.284B-2.42
Perspective Therapeutics, Inc. (CATX)United States$0.284B-3.34
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73